Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 2 Feb 24 EFFECT Notice of effectiveness
- 31 Jan 24 F-1/A Registration statement (foreign) (amended)
-
30 Jan 24 F-1/A Registration statement (foreign) (amended)
- 18 Jan 24 UPLOAD Letter from SEC
- 12 Jan 24 F-1 Registration statement (foreign)
EVAX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" and to the use of our report dated April 27, 2023 (which contains an explanatory paragraph describing conditions that raise substantial doubt about the Company’s ability to continue as a going concern as described in Note 2 to the consolidated financial statements), in Amendment No. 1 to the Registration Statement (Form F-1 No. 333-276505) and related Prospectus of Evaxion Biotech A/S for the registration of ordinary shares and warrants.
/s/ EY Godkendt Revisionspartnerselskab
Copenhagen, Denmark
January 30, 2024